Beyond the Single Dose: A 2026 Decision Framework for Azithromycin and Doxycycline in Chlamydia Care
Doxycycline has displaced single-dose azithromycin as the preferred regimen for most urogenital chlamydia, yet azithromycin retains a genuine and durable role in pregnancy, adherence-fragile patients, and partner-delivered therapy. This framework walks US clinicians through site-specific efficacy, counseling differences, and retesting obligations.